Skip to content
Ketamine Troche

Rapid-Acting Therapeutics

Articles tagged with “Rapid-Acting Therapeutics”

1 article
BXCL501 Enters Phase 2a for Acute Stress and PTSD Prevention — acute stress ketamine

BXCL501 Enters Phase 2a for Acute Stress and PTSD Prevention

BioXcel's sublingual dexmedetomidine enters a DoD-backed Phase 2a trial for acute stress reactions — what it means for the trauma treatment landscape.

Read
Back to all articles